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Problem Identification



Cigarette smoking is the leading cause of preventable death and disease
in the United States, accounting for more than 480,000 deaths every year
(1).



The adult smoking prevalence in Franklin County, VT, in 2017 was 16.6%,
approximately 1% higher than the national average (2,3).



In 2017, there were 134 opioid-related overdose deaths in Vermont—a rate
of 23.2 deaths per 100,000 persons and more than the national rate of 21.7
deaths per 100,000 persons (8).



The prevalence of tobacco use among substance abuse treatment
program enrollees has been shown to range between 75-97% (4,5).

Public Health Cost



Smoking-related illness in the US costs more than $300 billion each
year. This includes nearly $170 billion for direct medical care for
adults and more than $156 billion in lost productivity (1,6).



In Vermont, smoking costs the state approximately $348 million in
medical expenses and results in about 1000 smoking-attributable
deaths per year (7).

Community Perspective


In order to gain a community
perspective on this issue, I
spoke with Barbara Wynse,
one of the clinic’s MAT
coordinators, and an
anonymous patient currently
undergoing suboxone
treatment at the clinic.

• “For many patients who are
undergoing treatment for their
opioid use disorder, quitting
smoking is simply not as high of a
priority as getting and staying
sober.” – Barbara Wynes RN
• “It’s not that I don’t want to quit,
but every time I try, the stress in my
life drives me to pick it up again.
Sometimes I feel like it’d be harder
to stay sober if I wasn’t smoking.”
- Patient

Intervention and Methodology
•

Data collection
• A survey aimed at assessing quit attempt history,
current motivation to quit, and barriers to quitting was
developed and distributed to active smokers enrolled
in the clinic’s suboxone treatment program.
•

•

The “barriers” section of the survey is a modified version
of the BQS-SAT, a questionnaire originally developed
and verified by Asher et al (9) with the purpose of
assessing barriers to smoking cessation among patients in
substance abuse programs.

Intervention
• A handout with information comparing and
contrasting various quit aids and providing smoking
cessation resources available to Vermont residents
was created for distribution to the study population.

The
Handout

Results



Demographics


Total # of responses: 14



64.3% Male, 35.7% Female



Average # of cigarettes/day: 12.07



Average # of previous quit attempts: 3



93% tried at least 1 quit aid/nicotine replacement




Most commonly tried was the nicotine patch
(78.6%)

Motivation


Average importance of making changes in smoking
habits: 8.4/10



Average confidence in ability to make changes:
7.8/10



Average readiness to make changes: 8.3/10

Results
(cont.)



Barriers


Average # of barriers: 4.9



Top 3 most common barriers:





1) “If I quit smoking, I would feel anxious” (85.7%)



2) “When I don’t smoke, I feel restless and I can’t
concentrate” (64.3%)



3) “It’s hard to quit because so many others around me
are smoking” (50%)



3) “If I quit smoking, I would gain weight” (50%)

Top 3 most “important” barriers:


1) “If I quit smoking, my urges to use drugs will be so
strong, I won’t be able to stand it” (4/5)



2) “When I don’t’ smoke, I feel restless and I can’t
concentrate” (3.78/5)



3) “If I quit smoking, my urges to smoke will be so strong, I
won’t be able to stand it” (3.67/5)

Effectiveness
and
Limitations





Effectiveness:


The results of the survey provided Dr. Corrigan with useful
information regarding the trends in motivation to quit and barriers
to smoking cessation in his patient population. This information will
allow him and his staff to target the most common and important
barriers in their interventions and patient education.



One way to evaluate the effectiveness of the handout would be
to compare smoking rates, quit attempts, and quit aid use in the
study population before receiving the handout and at certain
time-points following the intervention (3, 6, 9 months).

Limitations:


Due to the time constraints of the clerkship, the sample size of the
study population was not large enough to yield statistically
significant results.



Because the surveys were completed anonymously, only
population data was gathered. This prevents Dr. Corrigan and his
staff from using the survey responses to tailor patient-specific
education and treatment plans.

Future
Directions



It would be useful to:
1.

Continue to distribute this survey at Dr. Corrigan’s clinic in
order to accumulate more responses and generate
statistically significant data.

2.

Perform a more in-depth statistical analysis comparing
number and types of barriers with information collected on
demographics, previous quit history, and motivation to
change.

3.

Distribute this survey and handout at other clinics in Franklin
county in order to obtain information that would be more
generalizable to the rest of the county and provide an
intervention to a broader patient population.



It would be useful to use this survey as a tool for creating patientspecific treatment plans, rather than as an anonymous datagathering instrument.



An interesting future project could compare barriers to smoking
cessation and motivation to quit in smokers enrolled in suboxone
treatment programs with smokers who have concurrent opioid use
disorder and are not enrolled in suboxone treatment programs.
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